NorthWest Health Prop Real Est Inv Trust (NWH.UN) Stock Price, News & Analysis

Company Overview

NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand. The REIT's portfolio of medical office buildings, clinics, and hospitals is characterized by long term indexed leases and stable occupancies. With a fully integrated and aligned senior management team, the REIT leverages 230 professionals across nine offices in five countries to serve as a long-term real estate partner to leading healthcare operators.

Key Stats

• Today's Range: C$4.41 to C$4.58
• 50-Day Range: C$4.45 to C$5.37
• 52-Week Range: C$3.93 to C$5.88
• Volume: 1.31 million shs
• Average Volume: 664,519 shs
• Market Capitalization: C$1.11 billion
• P/E Ratio: N/A
• Dividend Yield: 7.98%
• Price Target: C$5.42
• Consensus Rating: Hold

NorthWest Health Prop Real Est Inv Trust Stock Analysis - MarketRank™

NorthWest Health Prop Real Est Inv Trust scored higher than 32% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.1 / 5
• Analyst Rating: Hold

Consensus Rating

NorthWest Health Prop Real Est Inv Trust has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

NorthWest Health Prop Real Est Inv Trust has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of NorthWest Health Prop Real Est Inv Trust is -2.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of NorthWest Health Prop Real Est Inv Trust is -2.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

NorthWest Health Prop Real Est Inv Trust has a PEG Ratio of 0.74. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

NorthWest Health Prop Real Est Inv Trust has a P/B Ratio of 0.63. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for NWH.UN.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

NorthWest Health Prop Real Est Inv Trust is a leading dividend payer. It pays a dividend yield of 6.30%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

NorthWest Health Prop Real Est Inv Trust does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for NWH.UN.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: N/A

News Sentiment

NorthWest Health Prop Real Est Inv Trust has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.64 average news sentiment score of Real Estate companies.

News Coverage This Week

MarketBeat has tracked 1 news article for NorthWest Health Prop Real Est Inv Trust this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for NWH.UN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added NorthWest Health Prop Real Est Inv Trust to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, NorthWest Health Prop Real Est Inv Trust insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.31% of the stock of NorthWest Health Prop Real Est Inv Trust is held by insiders.

Percentage Held by Institutions

Only 23.77% of the stock of NorthWest Health Prop Real Est Inv Trust is held by institutions.

NWH.UN Stock Analysis - Frequently Asked Questions

How have NWH.UN shares performed this year?

NorthWest Health Prop Real Est Inv Trust's stock was trading at C$5.16 on January 1st, 2024. Since then, NWH.UN stock has decreased by 12.6% and is now trading at C$4.51.
View the best growth stocks for 2024 here.

How do I buy shares of NorthWest Health Prop Real Est Inv Trust?

Shares of NWH.UN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Real Estate
• Industry: REIT - Healthcare Facilities
• Sub-Industry: N/A
• Current Symbol: TSE:NWH.UN
• CUSIP: N/A
• CIK: N/A
• Web: www.nwhp.ca
• Phone: +1-416-3662000
• Fax: N/A
• Employees: 213
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: C$5.42
• High Stock Price Target: C$5.50
• Low Stock Price Target: C$5.25
• Potential Upside/Downside: +20.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): C($1.59)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 9.19
• P/E Growth: 0.74
• Net Income: C$-394,400,000.00
• Net Margins: -75.29%
• Pretax Margin: N/A
• Return on Equity: -14.67%
• Return on Assets: 2.91%

Debt

• Debt-to-Equity Ratio: 129.42
• Current Ratio: 0.25
• Quick Ratio: 0.06

Sales & Book Value

• Annual Sales: C$523.85 million
• Price / Sales: 2.12
• Cash Flow: C$0.21 per share
• Price / Cash Flow: 21.67
• Book Value: C$7.14 per share
• Price / Book: 0.63

Miscellaneous

• Outstanding Shares: 246,300,000
• Free Float: N/A
• Market Cap: C$1.11 billion
• Optionable: Not Optionable
• Beta: 1.05